iTeos Therapeutics, Inc.

Historical 13F Holders

Symbol
ITOS
CUSIP
46565G104
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 46565G104 since 12/18/2024, largest first.

Filer % of Class Filed
Tang Capital Management LLC 13D/A
100.0% 9/3/2025
Event 8/29/2025
EcoR1 Capital, LLC 13D
27.9% 5/16/2025
Event 5/15/2025
BlackRock Portfolio Management LLC 13G 6.1% 4/15/2025
Event 3/31/2025
BlackRock, Inc. 13G/A 5.7% 4/23/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
RA Capital Management, L.P. 13D/A
4.9% 5/19/2025
Event 5/15/2025
MPM BioVentures 2014, L.P. 13D/A
4.7% 5/15/2025
Event 5/13/2025
Biotechnology Value Fund L P 13G/A
0% 8/14/2025
Event 6/30/2025
Ridgeback Capital Investments L.P. 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 1 232 $2.36k
2025 Q2 138 37.8 M $377M
2025 Q1 133 37.0 M $221M
2024 Q4 140 34.1 M $262M
2024 Q3 153 36.6 M $373M
2024 Q2 140 36.2 M $537M
2024 Q1 138 34.6 M $471M
2023 Q4 140 35.0 M $383M
2023 Q3 144 35.5 M $388M
2023 Q2 147 34.8 M $460M
2023 Q1 154 36.0 M $489M
2022 Q4 148 36.3 M $708M
2022 Q3 145 36.6 M $698M
2022 Q2 156 37.3 M $768M
2022 Q1 161 36.1 M $1.17B
2021 Q4 120 33.4 M $1.55B
2021 Q3 78 31.2 M $841M
2021 Q2 84 29.5 M $756M
2021 Q1 82 30.1 M $1.03B
2020 Q4 72 26.9 M $907M
2020 Q3 55 25.0 M $614M